Discover why Europe's health-tech startups are attracting billions in VC investment, including predictions for growth and the rise of techbio and AI in healthcare.
Huma's FDA clearance for its disease-agnostic SaMD platform marks a milestone in digital health. With its regulatory approvals and validated algorithms, Huma is poised to empower partners in caring for more patients with fewer obstacles, revolutionizing patient care.
Predicting polyglutamine diseases is now easier with a new AI model that uses machine learning. Researchers at Niigata University in Japan developed the model, and it showed a higher prediction accuracy than other methods. Read the study, published in Neurology Genetics, to learn more.
Ezra's full-body MRI scanner detects potential signs of cancer and monitors hundreds of other conditions for early detection. Accessible and affordable to all, Ezra uses AI and aims to improve survival rates.